EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 106 filers reported holding EPIZYME INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,133,000 | -11.9% | 75,000 | 0.0% | 0.64% | +0.8% |
| Q1 2017 | $1,286,000 | -12.9% | 75,000 | -50.0% | 0.64% | +141.8% |
| Q3 2016 | $1,476,000 | -27.9% | 150,000 | -25.0% | 0.26% | -68.4% |
| Q2 2016 | $2,048,000 | +44.7% | 200,000 | +81.8% | 0.83% | +49.8% |
| Q3 2015 | $1,415,000 | -9.3% | 110,000 | +69.2% | 0.56% | +13.0% |
| Q2 2015 | $1,560,000 | – | 65,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |